Public Health
World COPD Day 2026: Early Diagnosis and Better Management
As the world marks World Chronic Obstructive Pulmonary Disease (COPD) Day 2026, attention is being drawn to the importance of early diagnosis, timely treatment and improved access to respiratory healthcare. Under the theme “Early Diagnosis and Management for a Better Life,” this year's campaign highlights the need to address delayed diagnosis and strengthen interventions that improve the quality of life of people living with COPD.
World Chronic Obstructive Pulmonary Disease (COPD) Day is observed annually to raise awareness about the disease, promote better understanding of its causes and symptoms, and encourage collective action to reduce its global burden.
The 25th World COPD Day takes place on 18 November 2026, under the theme “Early Diagnosis and Management for a Better Life.” Organised by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), this year's campaign highlights the consequences of underdiagnosis and misdiagnosis and the importance of identifying the condition earlier to improve treatment outcomes.
COPD is a chronic lung disease characterised by persistent respiratory symptoms and airflow obstruction, which makes breathing difficult. It includes conditions such as emphysema and chronic bronchitis and can progressively affect lung function, limiting a person's ability to perform everyday activities.
According to the World Health Organization (WHO), COPD caused approximately 3.4 million deaths worldwide in 2023, making it the third leading cause of death globally. Nearly 90 per cent of COPD deaths among people below 70 years occur in low- and middle-income countries.
The disease remains a significant public health concern in resource-limited settings, where exposure to household air pollution, occupational hazards and limited access to diagnostic services contribute to its burden.
Recognising the Symptoms and Risk Factors
COPD often develops gradually, and its early symptoms may be overlooked or mistaken for normal ageing, recurrent respiratory infections or the effects of smoking.
Common symptoms include:
• Persistent cough, sometimes accompanied by mucus production.
• Shortness of breath, particularly during physical activities.
• Wheezing.
• Chest tightness.
• Frequent respiratory infections.
• Persistent tiredness and reduced ability to exercise.
Several factors can contribute to the development of COPD. These include tobacco smoking, exposure to second-hand smoke, indoor and outdoor air pollution, occupational exposure to dust and harmful chemicals, and genetic conditions such as alpha-1 antitrypsin deficiency.
Early-life factors, including impaired lung development, premature birth and recurrent childhood respiratory infections, may also increase the risk of developing COPD later in life.
In Nigeria, exposure to smoke from firewood, charcoal and other biomass fuels is particularly relevant. Individuals who spend prolonged periods cooking in poorly ventilated environments may be exposed to harmful particles that affect respiratory health.
Understanding these risk factors is important because COPD is not exclusively a disease of smokers. People who have never smoked can also develop the condition following prolonged exposure to other harmful substances.
Why Early Diagnosis Matters:
1. One of the major challenges in COPD management is delayed or missed diagnosis. Many individuals experience respiratory symptoms for years without receiving appropriate medical assessment.
2. The gradual development of symptoms, limited awareness and inadequate access to diagnostic equipment can contribute to late identification. In some cases, patients may only seek medical attention when breathing difficulties become severe or begin to interfere significantly with daily activities.
3. Early diagnosis provides an opportunity to initiate appropriate treatment, reduce exposure to risk factors, manage symptoms and prevent avoidable complications.
Spirometry is essential for confirming a COPD diagnosis. It is a breathing test that measures the amount of air a person can forcefully exhale and how quickly they can do so.
According to GOLD diagnostic criteria, COPD is confirmed when spirometry performed after administration of a bronchodilator demonstrates a forced expiratory volume in one second to forced vital capacity ratio (FEV₁/FVC) below 0.70 in the appropriate clinical context.
The 2026 campaign therefore emphasises the importance of improving access to spirometry, strengthening healthcare professionals' capacity to recognise respiratory symptoms and increasing public awareness of the early warning signs of COPD.
Treatment and Management of COPD:
Although COPD currently has no cure, appropriate medical treatment and lifestyle modifications can relieve symptoms, reduce exacerbations, improve exercise tolerance and enhance patients' quality of life.
Management is individualised according to the patient's symptoms, disease severity, exacerbation history and other clinical factors.
Major management strategies include:
1. Bronchodilator therapy: Inhaled bronchodilators are central to COPD treatment. They relax the muscles surrounding the airways, helping to keep them open and making breathing easier. Depending on the patient's condition, short-acting or long-acting bronchodilators may be prescribed.
2. Inhaled corticosteroids: These medicines help reduce airway inflammation and may be recommended for selected patients, particularly those with recurrent exacerbations and clinical features suggesting a greater likelihood of benefit. They are commonly used in combination with long-acting bronchodilators rather than as routine treatment for every COPD patient.
3. Pulmonary rehabilitation: This involves structured exercise programmes, breathing techniques, nutritional guidance and patient education. It helps improve exercise capacity, reduce breathlessness and support better daily functioning.
4. Smoking cessation: Stopping smoking is one of the most important interventions for reducing further lung damage and slowing the decline in lung function. Patients should also be encouraged to avoid second-hand smoke and other respiratory irritants.
5. Vaccination: Recommended vaccinations, including influenza, pneumococcal and other appropriate vaccines, help reduce the risk of respiratory infections that may trigger COPD exacerbations.
6. Oxygen therapy: Long-term oxygen therapy may be prescribed for patients with severe COPD who have persistently low blood oxygen levels, following appropriate clinical assessment.
In addition to these interventions, patients should attend regular medical reviews, follow their prescribed treatment plans and ensure that their inhaler technique is correct.
Recognising worsening symptoms and seeking prompt medical attention are also essential aspects of effective disease management.
The Role of Pharmacists in COPD Care:
Pharmacists play an important role in improving treatment outcomes and supporting individuals living with COPD through medication management, patient education and collaboration with other healthcare professionals.
Their responsibilities include:
- Educating patients on the appropriate use of inhalers and other prescribed medications.
- Demonstrating correct inhaler techniques and regularly assessing patients' understanding.
- Promoting medication adherence and identifying potential drug-related problems.
- Counselling patients on smoking cessation and avoiding environmental respiratory irritants.
- Monitoring for possible adverse drug reactions and referring patients when necessary.
- Educating patients about recognising worsening symptoms and seeking timely medical attention.
- Supporting appropriate vaccination and preventive healthcare practices.
- Inhaler technique is particularly important because incorrect use can prevent patients from receiving the intended dose of medication. Pharmacists can help address this problem through practical demonstrations, counselling and regular follow-up.
Through these interventions, pharmacists contribute to better disease control, improved medication use and enhanced quality of life for people living with COPD.
Strengthening COPD Prevention and Respiratory Healthcare in Nigeria
In Nigeria, addressing COPD requires greater attention to environmental risk factors, public awareness and access to essential respiratory healthcare services.
Reducing exposure to household air pollution through cleaner cooking fuels, improved ventilation and safer cooking environments can help protect individuals from harmful airborne particles.
Public health interventions should also prioritise tobacco control, occupational safety, improved air quality and community education on respiratory health.
Furthermore, healthcare facilities need better access to spirometry equipment, trained personnel, essential respiratory medicines and pulmonary rehabilitation services.
Strengthening primary healthcare capacity to recognise persistent respiratory symptoms and identify individuals who require further assessment could also help reduce missed and delayed diagnoses.
Improved collaboration among pharmacists, physicians, nurses and other healthcare professionals is essential to ensuring that patients receive appropriate and continuous care.
A Call for Action:
As World COPD Day 2026 is commemorated, healthcare professionals, policymakers, communities and individuals are encouraged to prioritise respiratory health through early recognition, accessible diagnostic services and appropriate treatment.
Persistent cough, wheezing and breathlessness should never automatically be dismissed as normal signs of ageing. Individuals experiencing these symptoms, particularly those with a history of exposure to respiratory risk factors, should seek medical assessment.
Governments and healthcare institutions must also strengthen efforts to reduce environmental exposures, improve access to diagnostic services and make essential respiratory medicines more accessible, particularly in low- and middle-income countries.
Importantly, greater awareness must be accompanied by practical action. Early identification, appropriate treatment, preventive interventions and continuous patient support can make a meaningful difference in the lives of people affected by COPD.
Early diagnosis creates an opportunity to act before further lung function is lost. By strengthening awareness, improving access to respiratory care and supporting people living with COPD, we can work towards a future where more individuals breathe easier and live healthier lives.
References:
1. World Health Organization (WHO). (2026). Chronic obstructive pulmonary disease (COPD).
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2026). World COPD Day 2026.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2026). Global Strategy for the Diagnosis, Management, and Prevention of COPD: 2026 Report.
4. European Respiratory Society (ERS). (2026). Early diagnosis and management for a better life – World COPD Day 2026.